Return to Today's science sparks archives

2007-07-02

Fig 1D-E. Cartilage staining of e12.5 wild-type (D) and hnn (E) forelimbs shows an extra digit in the mutant.

Fig 1D-E. Cartilage staining of e12.5 wild-type (D) and hnn (E) forelimbs shows an extra digit in the mutant.
  • Caspary T, Larkins CE, Anderson KV

  • Dev Cell. 2007 May;12(5):767-78.

2007-07-03

Fig 1. Picturing a popcorn plaque.

Fig 1. Picturing a popcorn plaque.
  • Narula J, Strauss HW

  • Nat Med. 2007 May;13(5):532-4.

2007-07-05

Fig 2. Double contrast barium enema results show a colorectal carcinoma in the descending colon, evidenced by the filling defect (arrow) or ìapple-coreî appearance of the lesion.

Fig 2. Double contrast barium enema results show a colorectal carcinoma in the descending colon, evidenced by the filling defect (arrow) or ìapple-coreî appearance of the lesion.
  • Schmidt CR, Gollub MJ, Weiser MR

  • Surg Oncol Clin N Am. 2007 Apr;16(2):369-88.

2007-07-06

Fig 3. Merlin suppresses cell proliferation through multiple mechanisms.

Fig 3. Merlin suppresses cell proliferation through multiple mechanisms.
  • Okada T, You L, Giancotti FG

  • Trends Cell Biol. 2007 May;17(5):222-9.

2007-07-09

Fig 1D.  Venn diagram presenting the overlap among transcripts selectively expressed in hESC-derived mesenchymal precursors derived under stroma-free conditions (SF-3), hESC-derived mesenchymal precursors on OP9 (hESMPC-H9.1) and primary bone marrowñderived adult human MSCs.

Fig 1D. Venn diagram presenting the overlap among transcripts selectively expressed in hESC-derived mesenchymal precursors derived under stroma-free conditions (SF-3), hESC-derived mesenchymal precursors on OP9 (hESMPC-H9.1) and primary bone marrowñderived adult human MSCs.
  • Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, Studer L

  • Nat Med. 2007 May;13(5):642-8.

2007-07-10

Fig 5C. Hedgehog signaling cascade and its blockade by cyclopamine; Cyclopamine blocks the activity of Smo, maintaining the Gli proteins as transcriptional repressors (Gli-r).

Fig 5C. Hedgehog signaling cascade and its blockade by cyclopamine; Cyclopamine blocks the activity of Smo, maintaining the Gli proteins as transcriptional repressors (Gli-r).
  • Wunder JS, Nielsen TO, Maki RG, O'Sullivan B, Alman BA

  • Lancet Oncol. 2007 Jun;8(6):513-24.

2007-07-11

Fig 4A. Example of ADC maps, shown as color overlays on T2-weighted anatomical scans, for low-grade gliomas at 52 d after RCAS injection.

Fig 4A. Example of ADC maps, shown as color overlays on T2-weighted anatomical scans, for low-grade gliomas at 52 d after RCAS injection.
  • McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreger AR, Woolliscroft MJ, Rehemtulla A, Ross BD, Holland EC

  • Clin Cancer Res. 2007 May 15;13(10):2897-904.

2007-07-12

Protein interactions in the DNA damage response.

Protein interactions in the DNA damage response.
  • Petrini, John HJ

  • Science. 2007 May 25;316(5828):1138-9.

2007-07-13

Fig 1B. The screwdriver attaches to the extension screw in a counter bore located in the intercondylar notch.

Fig 1B. The screwdriver attaches to the extension screw in a counter bore located in the intercondylar notch.
  • Arkader A, Viola DC, Morris CD, Boland PJ, Healey JH

  • Clin Orthop Relat Res. 2007 Jun;459:60-5.

2007-07-16

Fig 2. Photomicrographs of the aorta of the WHHLMI rabbit.

Fig 2. Photomicrographs of the aorta of the WHHLMI rabbit.
  • Ishino S, Kuge Y, Takai N, Tamaki N, Strauss HW, Blankenberg FG, Shiomi M, Saji H

  • Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):889-99.

2007-07-17

Fig 3C. Repair of ischemic retinal vasculature in a mouse after injection of hES-BCs.

Fig 3C. Repair of ischemic retinal vasculature in a mouse after injection of hES-BCs.
  • Lu SJ, Feng Q, Caballero S, Chen Y, Moore MA, Grant MB, Lanza R

  • Nat Methods. 2007 June;4(6):501-9.

2007-07-18

Fig 8. FISH assay commonly used to detect chromosome aberrations in the absence of DSB response proteins.

Fig 8. FISH assay commonly used to detect chromosome aberrations in the absence of DSB response proteins.
  • Chaudhuri J, Basu U, Zarrin A, Yan C, Franco S, Perlot T, Vuong B, Wang J, Phan RT, Datta A, Manis J, Alt FW

  • Adv Immunol. 2007;94:157-214.

2007-07-19

Fig 2C. Gradient-echo (TR/TE = 1000 msec/54 msec) axial DSC MRI perfusion image with rCBV color overlay map, shows a lesion with very high perfusion, rCBV of 10.64 (arrows) in areas that are minimally enhancing.

Fig 2C. Gradient-echo (TR/TE = 1000 msec/54 msec) axial DSC MRI perfusion image with rCBV color overlay map, shows a lesion with very high perfusion, rCBV of 10.64 (arrows) in areas that are minimally enhancing.
  • Law M, Brodsky JE, Babb J, Rosenblum M, Miller DC, Zagzag D, Gruber ML, Johnson G

  • J Magn Reson Imaging. 2007 Jun;25(6):1113-9.

2007-07-20

Fig 4. Photomicrograph of a histologic section of nerves showing tumor involvement.

Fig 4. Photomicrograph of a histologic section of nerves showing tumor involvement.
  • Wang SQ, Goldberg LH, Nemeth A

  • J Am Acad Dermatol. 2007 Jun;56(6):1067-9.

2007-07-23

Fig 2F. Model of the SUMO E1 ubiquitin-like domain in complex with the non-covalent complex between Ubc9-SUMO-1 to illustrate that the two interactions may partially overlap.

Fig 2F. Model of the SUMO E1 ubiquitin-like domain in complex with the non-covalent complex between Ubc9-SUMO-1 to illustrate that the two interactions may partially overlap.
  • Capili AD, Lima CD

  • J Mol Biol. 2007 Jun 8;369(3):608-18.

2007-07-24

Fig B. Coronal section of left lung shows nodular involvement of visceral pleura and lung with focal zones of necrosis and hemorrhage.

Fig B. Coronal section of left lung shows nodular involvement of visceral pleura and lung with focal zones of necrosis and hemorrhage.
  • Tavora F, Rassaei N, Shilo K, Foss RD, Galvin JR, Travis WD, Franks TJ

  • Arch Pathol Lab Med. 2007 June;131(6):970-3.

2007-07-25

Fig 4. Polarized Cell Intercalation and Tissue Elongation.

Fig 4. Polarized Cell Intercalation and Tissue Elongation.
  • Jennifer Zallen

  • Cell. 2007 June 15;129(6):1051-63.

2007-07-26

Fig 1B. Serial frozen sections of a basal cell carcinoma where every fifth section was mounted and stained with toluidine blue.

Fig 1B. Serial frozen sections of a basal cell carcinoma where every fifth section was mounted and stained with toluidine blue.
  • Goldberg LH, Wang SQ, Kimyai-Asadi A

  • Dermatol Surg. 2007 June;33(6):761-3.

2007-07-27

Fig 3B. Fluorescence in situ hybridization showing increased copy number of KIT signals, with an average ratio KIT (Red) to centromere 4 (green) signals of 5:2 (Sample no. 20).

Fig 3B. Fluorescence in situ hybridization showing increased copy number of KIT signals, with an average ratio KIT (Red) to centromere 4 (green) signals of 5:2 (Sample no. 20).
  • Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP, Besmer P, Jungbluth A, Gimbel M, Chen CT, Veach D, Clarkson BD, Paty PB, Weiser MR

  • Int J Cancer. 2007 July 15;121(2):257-64.

2007-07-30

Fig 1. Tissue arrays with immunohistochemistry stains for various biologic markers.

Fig 1. Tissue arrays with immunohistochemistry stains for various biologic markers.
  • Riedl CC, Akhurst T, Larson S, Stanziale SF, Tuorto S, Bhargava A, Hricak H, Klimstra D, Fong Y

  • J Nucl Med. 2007 May;48(5):771-5.

2007-07-31

Fig 5B. ITGαvΒ6 expression potentiates cell migration; pBabe vector control- and Stat3-C-expressing RWPE-1 cells were plated onto glass- or fibronectin-coated culture slides in the presence of 6.3G9 antibody (bottom panels) or control IgG antibody (top panels), stained with phalloidin and anti-E-cadherin, and examined by confocal microscopy.

Fig 5B. ITGαvΒ6 expression potentiates cell migration; pBabe vector control- and Stat3-C-expressing RWPE-1 cells were plated onto glass- or fibronectin-coated culture slides in the presence of 6.3G9 antibody (bottom panels) or control IgG antibody (top panels), stained with phalloidin and anti-E-cadherin, and examined by confocal microscopy.
  • Azare J, Leslie K, Al-Ahmadie H, Gerald W, Weinreb PH, Violette SM, Bromberg J

  • Mol Cell Biol. 2007 June; 27(12):4444-53.

2007-08-01

Cover Image

Cover Image
  • Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C, Selleri L, Bromage TG, van Wijnen AJ, Stein GS, Lian JB, Vidal A, Koff A

  • Mol Cell Biol. 2007 July;27(14):5161-71.

2007-08-02

Fig 5A. Example of a patient with recurrent oropharyngeal carcinoma who underwent intensity-modulated radiation therapy to the base of the skull to a total dose of 70 Gy; Axial View.

Fig 5A. Example of a patient with recurrent oropharyngeal carcinoma who underwent intensity-modulated radiation therapy to the base of the skull to a total dose of 70 Gy; Axial View.
  • Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, Wolden S, Venkatraman ES, Pfister D, Kraus D, Shah J, Zelefsky MJ

  • Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):731-40.

2007-08-03

Fig 1Q. Profile view of E17.5 wildtype demonstrating normal craniofacial development in spite of the severe neural tube closure defect.

Fig 1Q. Profile view of E17.5 wildtype demonstrating normal craniofacial development in spite of the severe neural tube closure defect.
  • Zohn IE, Anderson KV, Niswander L

  • Dev Biol. 2007 June 1;306(1):208-21.

2007-08-06

Fig 1D. 3.5-year-old boy with abdominal Burkitt's lymphoma.

Fig 1D. 3.5-year-old boy with abdominal Burkitt's lymphoma.
  • Smith CS, Schöder H, Yeung HW

  • AJR Am J Roentgenol. 2007 June;188(6):1716-21.

2007-08-07

Fig 1A. A representative fluorescent image showing recruitment of BM-derived GFP+ VE-cadherin+ EPCs (arrows) at the periphery of early nonvascularized LLC tumors (days 4ñ6; n = 15).

Fig 1A. A representative fluorescent image showing recruitment of BM-derived GFP+ VE-cadherin+ EPCs (arrows) at the periphery of early nonvascularized LLC tumors (days 4ñ6; n = 15).
  • Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA, Benezra R, Mittal V

  • Genes Dev. 2007 June 15;21(12):1546-58.

2007-08-08

Fig 11A. The right panel shows a view of the helicase-DNA complex looking down the helical axis, with the putative Ku docking surface in the foreground.

Fig 11A. The right panel shows a view of the helicase-DNA complex looking down the helical axis, with the putative Ku docking surface in the foreground.
  • Sinha KM, Stephanou NC, Gao F, Glickman MS, Shuman S

  • J Biol Chem. 2007 May 18;282(20):15114-25.

2007-08-09

Fig 3C. p27, PCNA, CD3, and lysozyme expression in normal duodenal crypt epithelium.

Fig 3C. p27, PCNA, CD3, and lysozyme expression in normal duodenal crypt epithelium.
  • Smartt HJ, Guilmeau S, Nasser SV, Nicholas C, Bancroft L, Simpson SA, Yeh N, Yang W, Mariadason JM, Koff A, Augenlicht LH

  • Gastroenterology. 2007 July;133(1):232-43.

2007-08-10

 Fig 3B. Cisoid conformation of phenylalanine and AMP ligands in a phenylalanine adenylation domain active site (PheA; PDB 1AMU).

Fig 3B. Cisoid conformation of phenylalanine and AMP ligands in a phenylalanine adenylation domain active site (PheA; PDB 1AMU).
  • Cisar JS, Ferreras JA, Soni RK, Quadri LE, Tan DS

  • J Am Chem Soc. 2007 June 27;129(25):7752-3.

2007-08-13

 Fig 5A. Morphogenetic defects in the lulu neural plate.

Fig 5A. Morphogenetic defects in the lulu neural plate.
  • Lee JD, Silva-Gagliardi NF, Tepass U, McGlade CJ, Anderson KV

  • Development. 2007 June;134(11):2007-16.

2007-08-14

Fig 2. PG of bladder displaying cellular nests surrounded by a delicate vascular network.

Fig 2. PG of bladder displaying cellular nests surrounded by a delicate vascular network.
  • Samson W. Fine

  • Adv Anat Pathol. 2007 July;14(4):286-96.

2007-08-15

Fig 6. Positron emission tomography (PET) with fludeoxyglucose F 18 (FDG) images before and after treatment.

Fig 6. Positron emission tomography (PET) with fludeoxyglucose F 18 (FDG) images before and after treatment.
  • Gulec SA, Fong Y

  • Arch Surg. 2007 July;142(7):675-82.

2007-08-16

Fig 2D. The molecular model of the cage comprises 24 copies of the assembly unit with octahedral or 432 symmetry.

Fig 2D. The molecular model of the cage comprises 24 copies of the assembly unit with octahedral or 432 symmetry.
  • Fath S, Mancias JD, Bi X, Goldberg J

  • Cell. 2007 June 29;129(7):1325-36.

2007-08-17

Fig 4A. Variation in origin of common hepatic artery.

Fig 4A. Variation in origin of common hepatic artery.
  • Winston CB, Lee NA, Jarnagin WR, Teitcher J, DeMatteo RP, Fong Y, Blumgart LH

  • AJR Am J Roentgenol. 2007 July;189(1):W13-9.

2007-08-20

Fig 1. Signal Transduction by the HER Family and Potential Mechanisms of Action of Trastuzumab.

Fig 1. Signal Transduction by the HER Family and Potential Mechanisms of Action of Trastuzumab.
  • Clifford A. Hudis

  • N Engl J Med. 2007 July 5;357(1):39-51.

2007-08-21

Fig 2A. Overexpression of Nek3 potentiates PRL-mediated cytoskeletal re-organization of CHO transfectants.

Fig 2A. Overexpression of Nek3 potentiates PRL-mediated cytoskeletal re-organization of CHO transfectants.
  • Miller SL, Antico G, Raghunath PN, Tomaszewski JE, Clevenger CV

  • Oncogene. 2007 July 12;26(32):4668-78.

2007-08-22

Fig 1E. An HGPIN lesion, showing CRISP-3ñimmunoreactive cells.

Fig 1E. An HGPIN lesion, showing CRISP-3ñimmunoreactive cells.
  • Bjartell AS, Al-Ahmadie H, Serio AM, Eastham JA, Eggener SE, Fine SW, Udby L, Gerald WL, Vickers AJ, Lilja H, Reuter VE, Scardino PT

  • Clin Cancer Res. 2007 July 15;13(14):4130-8.

2007-08-23

Fig 6B. In epidermis of footpads of the CCI mice, some of the nerves either become fragmented or lost epidermal immunoreactivity (pink arrows).

Fig 6B. In epidermis of footpads of the CCI mice, some of the nerves either become fragmented or lost epidermal immunoreactivity (pink arrows).
  • Kolesnikov Y, El-Maarouf Abderrahman A, Rutishauser U, Pasternak G

  • Eur J Pharmacol. 2007 July 30;568(1-3):124-33.

2007-08-24

Fig 3A. Cell cycle and mitotic checkpoint gene interaction network in well-differentiated/dedifferentiated liposarcoma compared with normal fat.

Fig 3A. Cell cycle and mitotic checkpoint gene interaction network in well-differentiated/dedifferentiated liposarcoma compared with normal fat.
  • Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, Wu Y, O'Connor R, Maki R, Viale A, Sander C, Schwartz GK, Antonescu CR

  • Cancer Res. 2007 July 15;67(14):6626-36.

2007-08-27

Fig 5. Nectin-1 immunohistochemistry of excised MSKQLL1 murine flank tumors ...

Fig 5. Nectin-1 immunohistochemistry of excised MSKQLL1 murine flank tumors ...
  • Yu Z, Li S, Huang YY, Fong Y, Wong RJ

  • Cancer Gene Ther. 2007 Aug;14(8):738-47

2007-08-28

Fig 10. Schematic model of PTHR1 mediated signaling in osteosarcoma.

Fig 10. Schematic model of PTHR1 mediated signaling in osteosarcoma.
  • Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R

  • Int J Cancer. 2007 Sep 1;121(5):943-54.

2007-08-29

Fig 1. The Millennium Villages Project. Photo: Yoshi Shimizu/International Federation of Red Cross and Red Crescent Societies.

Fig 1. The Millennium Villages Project. Photo: Yoshi Shimizu/International Federation of Red Cross and Red Crescent Societies.
  • Kishore SP, Dhadialla PS

  • PLoS Med. 2007 July 24;4(7):e241.

2007-08-30

Cover image.

Cover image.
  • Li XF, Carlin S, Urano M, Russell J, Ling CC, O'Donoghue JA

  • Cancer Res. 2007 Aug 15;67(16):7646-53.

2007-09-04

Fig 1. Tertiary structure and active site of T4 Rnl1.

Fig 1. Tertiary structure and active site of T4 Rnl1.
  • Wang LK, Nandakumar J, Schwer B, Shuman S

  • RNA. 2007 Aug;13(8):1235-44.

2007-09-05

Fig 7A. Immunohistochemical staining of placenta with mAb CT7-33 to CT7/MAGE-C1.

Fig 7A. Immunohistochemical staining of placenta with mAb CT7-33 to CT7/MAGE-C1.
  • Jungbluth AA, Silva WA Jr, Iversen K, Frosina D, Zaidi B, Coplan K, Eastlake-Wade SK, Castelli SB, Spagnoli GC, Old LJ, Vogel M

  • Cancer Immun. 2007 Aug 24;7:15.

2007-09-06

Fig 1D. Xp11 translocation RCC mimicking renal lithiasis (case no. 15); Gross photograph of the tumor after fixation highlights the multicystic appearance, papillary architecture, and central calcification.

Fig 1D. Xp11 translocation RCC mimicking renal lithiasis (case no. 15); Gross photograph of the tumor after fixation highlights the multicystic appearance, papillary architecture, and central calcification.
  • Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M

  • Am J Surg Pathol. 2007 Aug;31(8):1149-60.

2007-09-07

Fig 7E. Effect of Id2 on the Negative Autoregulation of Hes1 in the Developing Chick Brain; Mechanism of NSC maintenance in early embryos.

Fig 7E. Effect of Id2 on the Negative Autoregulation of Hes1 in the Developing Chick Brain; Mechanism of NSC maintenance in early embryos.
  • Bai G, Sheng N, Xie Z, Bian W, Yokota Y, Benezra R, Kageyama R, Guillemot F, Jing N

  • Dev Cell. 2007 Aug;13(2):283-97.

2007-09-10

Fig 4. Examples of pS6-positive and pS6-negative renal cell carcinoma and colon carcinoma.

Fig 4. Examples of pS6-positive and pS6-negative renal cell carcinoma and colon carcinoma.
  • Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP

  • Cancer Res. 2007 Aug 1;67(15):7106-12.

2007-09-11

Fig 1A. Examples of low-grade serous carcinoma: Uniform nuclei.

Fig 1A. Examples of low-grade serous carcinoma: Uniform nuclei.
  • Malpica A, Deavers MT, Tornos C, Kurman RJ, Soslow R, Seidman JD, Munsell MF, Gaertner E, Frishberg D, Silva EG

  • Am J Surg Pathol. 2007 Aug;31(8):1168-74.

2007-09-12

Fig 2. EGF induces a switch in cten and tensin-3 expression, which is important for migration in epithelial cells.

Fig 2. EGF induces a switch in cten and tensin-3 expression, which is important for migration in epithelial cells.
  • Pylayeva Y, Giancotti FG

  • Nat Cell Biol.2007 Aug;9(8):877-9.

2007-09-13

Fig 1F. 46-year-old asymptomatic woman, 5 years after left breast lumpectomyÖ

Fig 1F. 46-year-old asymptomatic woman, 5 years after left breast lumpectomyÖ
  • Lee JM, Kaplan JB, Murray MP, Mazur-Grbec M, Tadic T, Stimac D, Liberman L

  • AJR Am J Roentgenol.2007 Aug;189(2):468-74.

2007-09-14

Fig 2.  Activity (in megabecquerels) over time (in days) for Tl-201 (red line), Tl-202 (yellow line), Tl-200 (green line), and Pb-203 (blue line), as well as total (purple line) for a 148-MBq injection at calibration under standard thallium kinetics.

Fig 2. Activity (in megabecquerels) over time (in days) for Tl-201 (red line), Tl-202 (yellow line), Tl-200 (green line), and Pb-203 (blue line), as well as total (purple line) for a 148-MBq injection at calibration under standard thallium kinetics.
  • Dauer LT, Williamson MJ, St Germain J, Strauss HW

  • J Nucl Cardiol.2007 Jul;14(4):582-8. Epub 2007 Jul 2.

2007-09-17

Fig 2E. The structural folds of individual subunits.

Fig 2E. The structural folds of individual subunits.
  • Chang YP, Wang G, Bermudez V, Hurwitz J, Chen XS

  • Proc Natl Acad Sci U S A.2007 Jul 31;104(31):12685-90. Epub 2007 Jul 25.

2007-09-18

Fig 4. Percentage of tumor necrosis map illustrating carboplatinís heterogeneous tumor response and the enhanced therapeutic effect of the region influenced by artificial lymphatic system (ALS) drainage.

Fig 4. Percentage of tumor necrosis map illustrating carboplatinís heterogeneous tumor response and the enhanced therapeutic effect of the region influenced by artificial lymphatic system (ALS) drainage.
  • DiResta GR, Aiken SW, Brown HK, Bergman PJ, Hohenhaus A, Ehrhart EJ, Baer K, Healey JH

  • Ann Surg Oncol.2007 Aug;14(8):2411-21. Epub 2007 May 15.

2007-09-19

Fig 3C. Tumor cells situated within and around neuropil-like islands exhibit strong immunoreactivity for NeuN.

Fig 3C. Tumor cells situated within and around neuropil-like islands exhibit strong immunoreactivity for NeuN.
  • Barbashina V, Salazar P, Ladanyi M, Rosenblum MK, Edgar MA

  • Am J Surg Pathol.2007 Aug;31(8):1196-202.

2007-09-20

Fig 3. Low-power view of the patient's radical prostatectomy specimen showing cancer invading beyond the prostatic boundaries into adipose tissue.

Fig 3. Low-power view of the patient's radical prostatectomy specimen showing cancer invading beyond the prostatic boundaries into adipose tissue.
  • Hill JR, Fine SW, Zhang J, Eastham JA

  • Nat Clin Pract Urol.2007 Aug;4(8):451-4.

2007-09-21

Fig 3D. immunohistochemical staining of GFP in tumors instilled with ACE-GFP 27 d after viral injection.

Fig 3D. immunohistochemical staining of GFP in tumors instilled with ACE-GFP 27 d after viral injection.
  • Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH

  • Clin Cancer Res.2007 Aug 1;13(15 Pt 1):4511-8.

2007-09-24

Fig 1. VEGF and VEGFR functions.

Fig 1. VEGF and VEGFR functions.
  • Riely GJ, Miller VA

  • Clin Cancer Res.2007 Aug 1;13(15 Pt 2):s4623-7.

2007-09-25

Fig 2. Functional magnetic resonance images of 60-year-old identical twins during a working memory task with incrementally increasing levels of difficulty (left to right).

Fig 2. Functional magnetic resonance images of 60-year-old identical twins during a working memory task with incrementally increasing levels of difficulty (left to right).
  • Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA

  • J Clin Oncol. 2007 Aug 1;25(25):3866-70.

2007-09-26

Fig 1. Steatosis. Fatty change, represented by the presence of fat droplets (arrow) within hepatocytes.

Fig 1. Steatosis. Fatty change, represented by the presence of fat droplets (arrow) within hepatocytes.
  • Nancy Kemeny

  • Oncologist. 2007 Jul;12(7):825-39.

2007-09-27

Fig 2. IMRT provides relative sparing of the spinal cord while delivering a full dose to the target volume.

Fig 2. IMRT provides relative sparing of the spinal cord while delivering a full dose to the target volume.
  • Yamada Y, Lovelock DM, Bilsky MH

  • Neurosurgery. 2007 Aug;61(2):226-35; discussion 235.

2007-09-28

Fig 3C. Schematic representation of the in vivo luminal killing assay.

Fig 3C. Schematic representation of the in vivo luminal killing assay.
  • Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG

  • J Exp Med. 2007 Aug 6;204(8):1891-900.

2007-10-01

Fig 1. Cancer immunoediting: from immunosurveillance to immunoevasion.

Fig 1. Cancer immunoediting: from immunosurveillance to immunoevasion.
  • Rescigno M, Avogadri F, Curigliano G

  • Biochim Biophys Acta 2007 Sep;1776(1):108-23.